A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Authors:
- Robert KarlssonRKRobert Karlsson
- Markus AlyMAMarkus Aly
- Mark ClementsMCMark Clements
- Lilly ZhengLZLilly Zheng
- Jan AdolfssonJAJan Adolfsson
- Jianfeng XuJXJianfeng Xu
- Henrik GrönbergHGHenrik Grönberg
- Fredrik WiklundFWFredrik Wiklund
- 1 January 2014
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 65 (1) , 169-176
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Cancer Epidemiology, Biomarkers & Prevention, 2012
- Genetic variants associated with predisposition to prostate cancer and potential clinical implicationsJournal of Internal Medicine, 2012
- Germline Mutations inHOXB13and Prostate-Cancer RiskNew England Journal of Medicine, 2012
- Evaluation of Multiple Risk–Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened MenEuropean Urology, 2011
- Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort StudyEuropean Urology, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2011
- Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancerThe Prostate, 2010
- Cumulative Association of Five Genetic Variants with Prostate CancerNew England Journal of Medicine, 2008
- Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Scandinavian Journal of Urology and Nephrology, 2007
- Prostate cancer epidemiologyThe Lancet, 2003